Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Rova-T
Rova-T
AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial
Marketwatch
Mon, 07/25/16 - 10:55 am
AbbVie
Bristol-Myers Squibb
lung cancer
clinical trials
Rova-T
Opdivo
Why AbbVie Expects Rova-T to Earn so Big in Peak Sales
Marketwatch
Sun, 07/10/16 - 12:07 pm
AbbVie
Rova-T
Stemcentrx
lung cancer
Understanding Trinity: Inside the Testing of AbbVie’s Rova-T
Marketwatch
Fri, 07/1/16 - 12:15 pm
AbbVie
Rova-T
small cell lung cancer
AbbVie's Rova-T Update at ASCO: Good or Bad?
Motley Fool
Sun, 06/12/16 - 09:54 pm
AbbVie
Rova-T
ASCO 2016
small cell lung cancer
What AbbVie Bought for $5.8 Billion
Motley Fool
Mon, 06/6/16 - 11:25 am
AbbVie
Stemcentrx
M&A
Rova-T
lung cancer
AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
Forbes
Sun, 06/5/16 - 11:50 am
AbbVie
Rova-T
non-small cell lung cancer
ASCO 2016
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Pages
« first
‹ previous
1
2